Clinical Guides
Dysmenorrhoea
A clinically reasoned guide to primary and secondary dysmenorrhoea for Indian medical learners, based on current professional guidance and awaiting mandatory specialist review.
MedNext Academy | 14 min read
Dysmenorrhoea
A clinically reasoned guide to primary and secondary dysmenorrhoea for Indian medical learners, based on current professional guidance and awaiting mandatory specialist review.
Summary
Dysmenorrhoea means pain associated with menstruation. Primary dysmenorrhoea is recurrent menstrual pain without an identified pelvic disorder; secondary dysmenorrhoea is pain caused by a condition such as endometriosis, adenomyosis, fibroids, pelvic infection or an obstructive reproductive-tract anomaly. The distinction is a working clinical formulation, not permission to dismiss severe pain as normal. Pain that prevents school, work, sleep, movement or ordinary activity deserves assessment and treatment.
Primary dysmenorrhoea typically produces cramping suprapubic pain beginning shortly before or around the onset of bleeding, peaking early in the period and improving over two or three days. Back or thigh pain, nausea, diarrhoea, headache, dizziness and fatigue can accompany it. Prostaglandin-driven uterine contractions and ischaemia are central mechanisms. A typical history without red flags often supports empiric treatment without a pelvic examination or invasive test.
Features suggesting secondary disease include pain beginning immediately at menarche, progressive worsening, pain outside menstruation, heavy or irregular bleeding, deep dyspareunia, dyschezia, cyclical urinary symptoms, infertility, pelvic mass, infection risk or failure of an adequate first-line trial. A normal examination or ultrasound does not exclude endometriosis.
First-line treatment for likely primary dysmenorrhoea includes an appropriate non-steroidal anti-inflammatory drug and/or hormonal menstrual suppression when contraception and patient preference permit. Heat and regular physical activity can be offered as adjuncts, while unsupported cure claims should be avoided. Review response, adherence, adverse effects and diagnostic assumptions. Persistent or atypical symptoms require evaluation for secondary causes rather than escalating self-medication. This guide is educational and does not authorise patient-specific prescribing.
How Common Is It?
Dysmenorrhoea is among the most frequently reported menstrual symptoms, particularly in adolescents and young adults. Published prevalence varies widely because studies use different pain thresholds, age groups, sampling methods and questions about functional impact. The 2025 SOGC guideline describes it as common and often undertreated. This guide therefore avoids presenting a single percentage as if it applied to every Indian school, college, clinic or community.
Clinical burden is more informative than frequency alone. Menstrual pain can disrupt attendance, examinations, paid work, sleep, exercise, travel, relationships and mental well-being. People may normalise severe symptoms, conceal them because of stigma, or rely on repeated over-the-counter medicines without an assessment. Under-recognition can delay both effective primary-dysmenorrhoea care and diagnosis of secondary conditions.
Primary dysmenorrhoea often begins after ovulatory cycles become established rather than necessarily with the first menstrual period. Its severity may change with age, hormonal contraception, pregnancy history or other health factors, but none of these establishes the diagnosis. Secondary dysmenorrhoea can appear later, evolve progressively or coexist with an earlier primary pattern.
Indian prevalence estimates from single institutions or student surveys are not nationally representative. Differences in school attendance, product access, willingness to discuss menstruation and health-care access can alter reported rates. A sound consultation asks how the pain affects the individual, what has changed, which treatments were actually tried and whether secondary-disease features are present.
Risk Factors
Primary dysmenorrhoea is associated with ovulatory menstrual cycles and may cluster with earlier menarche, longer or heavier bleeding, smoking, family history and psychosocial stress in observational literature, but associations do not prove cause in an individual. The clinically useful risk question is whether the pattern is typical and stable or whether evidence points to a secondary disorder.
Endometriosis becomes more likely when dysmenorrhoea is progressive, impairs daily activities, accompanies deep dyspareunia, dyschezia, cyclical bowel or urinary symptoms, chronic pelvic pain or infertility, or occurs in a person with an affected first-degree relative. current guidelines explicitly recommends asking about family history. Adenomyosis may combine heavy bleeding with progressive pain and a tender bulky uterus. Fibroids can produce pressure, bleeding or pain depending on size and location.
Pelvic inflammatory disease risk is informed by sexual history, new partners, barrier use, previous sexually transmitted infection, discharge, fever and pelvic tenderness. An obstructive Müllerian anomaly should be considered when severe pain begins soon after menarche, particularly if bleeding is absent, scant or associated with a pelvic mass. A copper intrauterine device can increase cramping and bleeding, especially after insertion, whereas new severe pain also requires exclusion of expulsion, perforation, infection or pregnancy.
Trauma, pelvic-floor pain, irritable bowel syndrome, bladder pain syndrome and musculoskeletal pain can coexist and change the experience of cyclical pain. Risk-factor assessment must be confidential, age-appropriate and non-judgmental. It guides examination and testing; it must not be used to deny analgesia or to assume endometriosis without evaluating competing diagnoses.
Diagnosis
Diagnosis starts by characterising the relationship between pain and menstruation, identifying functional impairment and looking for secondary features. Confirm haemodynamic stability and exclude a pregnancy-related emergency whenever pregnancy is possible. A prospective symptom and bleeding diary over several cycles can clarify timing and response, but urgent symptoms should never wait for diary completion.
History
Ask when pain began relative to menarche, whether it starts before or with bleeding, how long it lasts, whether it occurs between periods and whether it is worsening. Record location, radiation, severity, nausea, vomiting, bowel or urinary symptoms, fainting, headache and effect on school, work, sleep and activity. Clarify cycle regularity, bleeding amount, intermenstrual or postcoital bleeding, discharge, fever, dyspareunia and fertility concerns. Review sexual and pregnancy history sensitively, contraception, procedures, medicines, gastrointestinal or renal disease, prior imaging and exact treatment timing, dose adherence and response.
Examination
Check observations and assess for pallor, dehydration, acute abdominal signs and a mass. A typical primary pattern in an adolescent or adult does not automatically require pelvic examination before initial treatment. Examination becomes important with atypical symptoms, treatment failure, abnormal bleeding, discharge, mass, dyspareunia or concern for infection or secondary pathology. Explain the purpose, obtain consent, use a chaperone and choose abdominal, external or internal examination according to age, history and acceptability.
Investigations
No routine laboratory or imaging panel confirms primary dysmenorrhoea. Perform pregnancy testing when conception is possible. Full blood count is appropriate with heavy bleeding, pallor or systemic symptoms; infection testing is risk-directed. Pelvic ultrasound is used when secondary disease or an anomaly is suspected or when symptoms persist despite adequate treatment. Transabdominal imaging may be more acceptable when internal scanning is unsuitable. For suspected endometriosis, current guidelines recommends transvaginal ultrasound even with a normal examination, while emphasising that normal imaging does not exclude disease. MRI and laparoscopy are specialist, question-directed tests rather than routine confirmation of primary dysmenorrhoea.
Differential Diagnosis
Primary dysmenorrhoea is a diagnosis supported by a typical cyclical pattern and low suspicion of pelvic pathology. Endometriosis is the leading secondary consideration when pain is progressive, function-limiting or associated with deep dyspareunia, dyschezia, cyclical bowel or urinary symptoms, chronic pelvic pain or infertility. It may be present despite normal examination and ultrasound. Adenomyosis often causes heavy bleeding with progressive dysmenorrhoea and uterine tenderness; fibroids or polyps can add pressure or abnormal bleeding.
Pelvic inflammatory disease may cause bilateral lower abdominal pain, fever, discharge, abnormal bleeding and cervical or adnexal tenderness. Ovarian cyst accident or torsion typically presents with acute or unilateral severe pain and vomiting rather than a stable recurrent pattern. Pregnancy-related causes, especially ectopic pregnancy or miscarriage, must be excluded when pregnancy is possible. Obstructive anomalies can cause severe pain from menarche with absent or limited outflow and a pelvic mass.
Non-gynaecological mimics include appendicitis, urinary infection, renal colic, inflammatory bowel disease, irritable bowel syndrome, constipation, bladder pain syndrome, abdominal wall pain and pelvic-floor myalgia. Migraine, nausea and diarrhoea may accompany primary dysmenorrhoea but can also represent separate conditions. Sexual trauma or safeguarding concerns require a trauma-informed response without implying a psychogenic explanation for pain.
Premenstrual syndrome and premenstrual dysphoric disorder have a luteal-phase pattern dominated by affective or broader physical symptoms and remit after menstruation begins; they should not be used interchangeably with dysmenorrhoea. Keep the formulation open when symptoms are mixed, because concurrent primary dysmenorrhoea, endometriosis and non-gynaecological pain are possible.
Management
Begin by validating the pain, agreeing a functional goal and explaining the difference between symptom treatment and evaluation for secondary disease. For a typical primary pattern, current professional guidance supports treatment without waiting for pelvic examination or invasive diagnosis. Record baseline severity, activity restriction and medicine use so that response can be assessed rather than guessed.
An NSAID is a first-line option when not contraindicated because it suppresses prostaglandin production. Effect is greatest when started just before expected pain or at its onset and taken on a regular verified schedule through the most symptomatic days. If cycles are unpredictable, start at symptom onset. Failure may reflect late initiation, inadequate adherence, intolerable adverse effects or an incorrect diagnosis; it should not lead to unlimited dose escalation.
Hormonal contraception or menstrual suppression is another first-line approach when acceptable and medically suitable. Combined hormonal methods and progestogen-only options, including an LNG-IUS, can reduce pain by suppressing ovulation or endometrial activity. Choice depends on contraception goals, bleeding preference, medical eligibility, privacy, affordability and ability to follow up. A method should not be presented as mandatory or as proof that pain is benign.
Offer heat, sleep support and regular physical activity as low-risk adjuncts. Evidence for many supplements, herbal products and devices is inconsistent, so discuss uncertainty and interactions. Review after a defined trial. If pain remains important after approximately three to six months of correctly used therapy, or sooner when features are atypical, evaluate adherence and secondary causes. Suspected endometriosis can be assessed and treated in parallel; a normal scan is not the end of the pathway.
Prescribing Information
This section teaches safe selection, not a personalised regimen. Before recommending an NSAID, check pregnancy possibility, allergy or aspirin sensitivity, asthma reactions, peptic ulcer or gastrointestinal bleeding, kidney disease, cardiovascular risk, anticoagulants, platelet disorders and concurrent NSAID use. Use one verified product at the lowest effective dose for the shortest necessary period according to the current Indian label. Taking it with food may reduce dyspepsia but does not eliminate ulcer or renal risk. Stop and seek care for gastrointestinal bleeding, severe wheeze, facial swelling, marked reduction in urine or other serious reactions.
Paracetamol may be considered when NSAIDs are unsuitable or as part of a clinician-directed plan, but should not be assumed equivalent for prostaglandin-mediated pain. Check all combination cold and analgesic products to prevent accidental duplication. Opioids are not routine treatment for recurrent dysmenorrhoea because harms, sedation, tolerance and dependence can outweigh benefit.
Before combined hormonal contraception, assess migraine with aura, smoking and age, blood pressure, venous thromboembolism, cardiovascular or liver disease, breast cancer, postpartum status and interacting medicines using current eligibility guidance. Progestogen-only pills, implants, injections and LNG-IUS have distinct contraindications, bleeding patterns, duration and return-to-fertility implications. Explain that hormonal treatment can mask cycle patterns and is contraceptive unless a non-contraceptive regimen is specifically selected.
Document expected benefit, common adverse effects, missed-dose or device advice, warning symptoms and a review date. Do not prescribe empirically through unexplained progressive pain, a pelvic mass, pregnancy-related symptoms or infection. Indian brand availability changes; use generic names, verify the label and avoid copying a dose from an educational page into clinical practice.
When to Refer
Refer urgently for haemodynamic instability, collapse, a possible pregnancy with pain or bleeding, peritonism, fever or sepsis features, acute severe unilateral pain with vomiting, a tender mass, urinary retention, bowel obstruction symptoms or uncontrolled pain with dehydration. These presentations require emergency evaluation for ectopic pregnancy, torsion, infection, haemorrhage or another acute abdomen, not a routine dysmenorrhoea appointment.
Arrange gynaecology referral when pain is severe or progressively worsening, begins immediately after menarche, occurs outside periods, is associated with heavy or irregular bleeding, deep dyspareunia, dyschezia, cyclical urinary symptoms, infertility, abnormal examination or imaging, or persists after an adequate three-to-six-month first-line trial. Current guidelines recommends referral for suspected endometriosis when initial treatment is ineffective, not tolerated or contraindicated, symptoms impair daily living, symptoms recur, or pelvic signs are present.
Refer suspected endometrioma, deep endometriosis involving bowel, bladder or ureter, or extrapelvic disease to a service with relevant expertise. Adolescents with suspected endometriosis or a congenital anomaly benefit from paediatric and adolescent gynaecology where available. Consider pain, pelvic-floor, gastroenterology, urology or mental-health support when a broader multidisciplinary formulation is needed; this should complement, not replace, investigation of gynaecological disease.
The referral should describe chronology, functional impact, bleeding pattern, associated bowel, urinary and sexual symptoms, pregnancy result, examination, imaging, treatments actually tried and adherence, adverse effects, red flags and patient priorities. Clear documentation reduces repeated dismissal and allows the receiving service to act.
Red Flags
Severe pelvic pain with a late period, positive pregnancy test, vaginal bleeding, shoulder-tip pain, dizziness, syncope or shock requires urgent ectopic-pregnancy assessment. Sudden unilateral pain with vomiting raises concern for ovarian torsion or cyst complication. Fever, purulent discharge, marked pelvic tenderness, guarding, rebound or toxic appearance suggests infection or another acute abdominal process. These are not safely explained by a history of painful periods.
Progressive pain, pain outside menstruation, deep dyspareunia, painful defaecation, cyclical haematuria, infertility or repeated failure of appropriate treatment raises suspicion for endometriosis or other secondary disease. Heavy or irregular bleeding, postcoital bleeding, unexplained weight loss, a pelvic mass or an abnormal cervix requires a wider evaluation. Severe pain from the first cycles after menarche with absent or scant outflow can indicate an obstructive anomaly.
Medicine-related red flags include haematemesis, melaena, severe wheeze, facial swelling, oliguria, chest pain, acute breathlessness, unilateral leg swelling, focal neurological symptoms or jaundice. Repeated use of several NSAID-containing products creates avoidable gastrointestinal and renal risk.
Pain with suicidal thoughts, self-harm, safeguarding risk or inability to function requires direct support and urgent mental-health assessment as appropriate. Psychological distress does not make the pelvic symptoms unreal. Safety-netting should name the urgent features, where to seek care and when to return if the expected response does not occur.
Indian Clinical Context
No current Indian statutory, condition-specific national dysmenorrhoea guideline was identified for this draft. The management framework therefore uses the 2025 SOGC primary-dysmenorrhoea guideline and current endometriosis guidance, then states where local Indian product information, service access and clinical protocols must govern practice. The NMC curriculum supplies educational anchors but is not a prescribing manual. This limitation should remain visible during review.
In India, school or workplace absence, limited toilet privacy, difficulty buying menstrual products, travel to specialist services and reluctance to discuss sexual symptoms can shape presentation. A private, non-judgmental consultation is important, particularly for adolescents. Ask permission before sexual history or pelvic examination and do not condition pain relief on disclosure, marital status or an internal examination. Where paediatric gynaecology or specialist endometriosis imaging is unavailable, document the safest interim plan and referral route.
Generic NSAIDs and hormonal methods may be widely available, but over-the-counter access does not make repeated unsupervised dosing safe. Verify current Indian labels, contraindications and interactions. Do not endorse proprietary combinations, traditional products or supplements merely because they are marketed for period pain. If a patient uses them, ask respectfully about ingredients and potential interaction rather than demanding concealment.
Indian prevalence studies are heterogeneous and often institution-based; no national prevalence figure is claimed. The practical equity goal is prompt recognition of function-limiting pain, safe initial therapy, pregnancy and infection assessment when indicated, and a credible route to secondary-disease evaluation rather than normalising disability.
NMC Competency Mapping
The NMC CBME Curriculum 2024 does not provide a standalone dysmenorrhoea competency code that should be invented for this guide. Dysmenorrhoea is best taught through integrated Obstetrics and Gynaecology competencies. OG24.1 covers abnormal uterine bleeding and is relevant when painful periods coexist with heavy, irregular or intermenstrual bleeding. OG26.1 covers the aetiopathogenesis, clinical features, investigation and health or fertility implications of endometriosis and adenomyosis, key secondary causes of dysmenorrhoea. Normal menstrual physiology and pharmacology provide horizontal integration.
At the Know level, learners should define primary and secondary dysmenorrhoea, explain prostaglandin-mediated pain and list important secondary causes. At Know How level, they should recognise a typical cyclical history, identify red flags, determine pregnancy and infection risk, decide when examination or imaging is required and select a safe first-line approach. A normal ultrasound must not be used to exclude endometriosis.
At Show How level, a learner can take a sensitive menstrual, sexual and functional history in a supervised or simulated setting; explain examination and obtain consent; counsel on correct NSAID timing and hormonal options without prescribing beyond competence; and construct a referral for persistent or atypical symptoms.
Formal assessment should test clinical reasoning rather than memorised brand doses. A safe answer validates pain, distinguishes emergency from routine care, treats likely primary dysmenorrhoea, reviews response and reopens the diagnosis when treatment fails. Institutions should confirm the current local competency ledger before assigning this guide to a coded session.
Key Exam Pearls for NEET PG
Primary dysmenorrhoea is painful menstruation without identified pelvic pathology; secondary dysmenorrhoea has an underlying cause. Primary pain is typically crampy and suprapubic, begins shortly before or at bleeding, peaks early and resolves within two or three days. It reflects increased endometrial prostaglandin activity and uterine contractions. A typical history can justify empiric treatment without routine pelvic examination or investigations.
NSAIDs are first-line and work best when started before expected pain or at symptom onset and continued on a verified schedule through the painful days. Hormonal menstrual suppression is also first-line when suitable. Heat and exercise may be adjuncts. Do not select an opioid as routine recurrent therapy, and do not escalate several OTC products without checking ingredients and contraindications.
Think secondary disease when pain starts immediately after menarche, worsens progressively, becomes acyclic, accompanies heavy or irregular bleeding, deep dyspareunia, dyschezia, cyclical urinary symptoms, infertility, a mass or treatment failure. Endometriosis can be present despite normal examination and ultrasound. Current guidelines advises ultrasound and referral in parallel with initial treatment when endometriosis is suspected.
In acute severe pain, first exclude ectopic pregnancy, torsion, infection and other surgical causes. In an adolescent with severe cyclical pain and absent or scant menstrual outflow, consider an obstructive Müllerian anomaly. The examination answer sequence is: assess stability and pregnancy possibility, characterise the cycle-linked pattern, identify secondary features, start safe first-line treatment, plan review, and refer persistent or complex disease.
Frequently Asked Questions
Is severe period pain normal if the menstrual cycle is regular?
Regular cycles do not make disabling pain normal or harmless. A typical cyclical pattern may be primary dysmenorrhoea and can be treated, but severity, progressive change, pain outside periods, abnormal bleeding, dyspareunia, bowel or urinary symptoms, infertility and treatment failure should prompt evaluation for secondary causes. The practical threshold for care is impact on life, not whether other people also experience cramps.
Does everyone with dysmenorrhoea need a pelvic examination or ultrasound?
No. A typical primary pattern without red flags can receive initial treatment without a pelvic examination or routine imaging. Examination and ultrasound become important when symptoms are atypical, progressive, associated with abnormal bleeding or infection, or persist despite adequate treatment. When endometriosis is suspected, ultrasound can find endometrioma or deep disease, but a normal result does not exclude superficial endometriosis.
When should an anti-inflammatory medicine be started for period pain?
An NSAID usually works best when started shortly before an expected period or at the first sign of pain or bleeding, then taken on the verified schedule during the most painful days. Suitability must be checked first because ulcer disease, kidney disease, some asthma reactions, anticoagulants and other risks may make NSAIDs unsafe. Do not combine multiple NSAID-containing products or copy a dose from this guide.
When should endometriosis be suspected in someone with painful periods?
Suspicion rises when pain progressively worsens, limits daily activity, occurs between periods, accompanies deep dyspareunia, painful defaecation, cyclical bowel or urinary symptoms, infertility, a first-degree family history, or persists despite correctly used first-line treatment. Examination and ultrasound can be normal. Persistent symptoms deserve a documented evaluation and referral pathway rather than repeated reassurance or indefinite self-medication.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic